![]() |
Trials |
A PHASE IA/IB OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF RO7198457 AS A SINGLE AGENT AND IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC TUMORSCancer type: Multiple diagnosis Phase: I Principal Investigator: Yachnin Jeffrey Country: SE Keywords: Sweden, Stockholm, GO39733 Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03289962?term=GO39733&rank=1 |